FAST NEWS: Nomura takes up Kintor Pharma stake
The latest: Japanese financial group Nomura Holdings disclosed it purchased 5.91 million shares of Kintor Pharmaceutical Ltd. (9939.HK) on Jun. 1, raising its stake in the biotech company from 4.06% to 5.39%,…
FAST NEWS: Kintor Pharma hits new low as loss keeps growing
The latest: Kintor Pharmaceutical Ltd. (9939.HK) announced on Thursday it did not record any revenue last year, as its net loss widened 13.3% to 954 million yuan ($139 million) from 842 million…
FAST NEWS: Kintor Pharma Raises $65 Million for Drug Commercialization
The latest: Kintor Pharmaceutical Ltd. (9939.HK) announced on Sunday that it will place 42 million shares, representing approximately 10.3% of its enlarged capital after the issue. It will sell the…
Genuine Biotech Seeks IPO Booster from New Oral Covid Drug
Company hopes China’s approval of its small molecule oral Covid-19 drug will draw investors to its newly filed listing plan Key Takeaways: Genuine Biotech has filed to list in Hong…
FAST NEWS: Kintor Pharma Soars on Good Results for Covid Drug
The latest: Kintor Pharmaceutical Ltd. (9939.HK) on Wednesday announced positive results from a Phase 3 clinical trial for its drug Proxalutamide for the treatment of mild-to-moderate ambulatory Covid-19 patients, saying…
Recent Articles
RELATED ARTICLES
-
Kintor Pharma eyes regeneration with over-the-counter cosmetic treatments
9939.HK -
Everest Medicines eyes mRNA tumor vaccines as drug valuations rebound
1952.HK
-
Akeso marks profit milestone with swift rights issue
9926.HK
-
Facing revenue crisis, Ascletis Pharma tries to bulk up with obesity drugs
1672.HK
-
Profit setback for Simcere Pharma in novel drugs quest
2096.HK
-
Ascentage Pharma soars on deal with cancer drug competitor
6855.HK
